| Full Name | Peter D Cao |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 1575 I 30, Mesquite, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356635049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10041302 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Home Health Group Of Mckinney, Llc | Mckinney, TX | Home health agency |
| Baylor University Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Driver distractions have joined alcohol and speeding as leading factors in fatal and serious injury crashes. The National Safety Council estimates that up to 25 percent of all crashes in 2008 involved talking on cell phones or texting. To combat this growing threat on our roadways, the State of California has added Distracted Driving as the first new area for concentrated effort to the Strategic Highway Safety Plan.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
A new study published in the Journal of the American Medical Association finds that students and school employees are being poisoned by pesticide use at schools and from drift off of neighboring farmlands. The public health advocacy organization Beyond Pesticides has called on Congress to respond by passing the School Environment Protection Act (SEPA).
Meanwhile, a Colorado legislator seeks to force the governor to ask for a waiver to change the Medicaid program.
A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule is active in the cells that surround a tumor cell, this "tumor microenvironment" becomes less hospitable to cancer growth. When the molecule is deficient, cancer thrives.
› Verified 7 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Driver distractions have joined alcohol and speeding as leading factors in fatal and serious injury crashes. The National Safety Council estimates that up to 25 percent of all crashes in 2008 involved talking on cell phones or texting. To combat this growing threat on our roadways, the State of California has added Distracted Driving as the first new area for concentrated effort to the Strategic Highway Safety Plan.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
A new study published in the Journal of the American Medical Association finds that students and school employees are being poisoned by pesticide use at schools and from drift off of neighboring farmlands. The public health advocacy organization Beyond Pesticides has called on Congress to respond by passing the School Environment Protection Act (SEPA).
Meanwhile, a Colorado legislator seeks to force the governor to ask for a waiver to change the Medicaid program.
A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule is active in the cells that surround a tumor cell, this "tumor microenvironment" becomes less hospitable to cancer growth. When the molecule is deficient, cancer thrives.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter D Cao, MD Po Box 847824, Dallas, TX 75284-7824 Ph: (903) 877-7777 | Peter D Cao, MD 1575 I 30, Mesquite, TX 75150-6905 Ph: (469) 800-2800 |
News Archive
Driver distractions have joined alcohol and speeding as leading factors in fatal and serious injury crashes. The National Safety Council estimates that up to 25 percent of all crashes in 2008 involved talking on cell phones or texting. To combat this growing threat on our roadways, the State of California has added Distracted Driving as the first new area for concentrated effort to the Strategic Highway Safety Plan.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
A new study published in the Journal of the American Medical Association finds that students and school employees are being poisoned by pesticide use at schools and from drift off of neighboring farmlands. The public health advocacy organization Beyond Pesticides has called on Congress to respond by passing the School Environment Protection Act (SEPA).
Meanwhile, a Colorado legislator seeks to force the governor to ask for a waiver to change the Medicaid program.
A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule is active in the cells that surround a tumor cell, this "tumor microenvironment" becomes less hospitable to cancer growth. When the molecule is deficient, cancer thrives.
› Verified 7 days ago
Dr. Westley Eugene Raborn, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2704 N Galloway Ave, Ste 103, Mesquite, TX 75150 Phone: 214-660-2500 Fax: 214-660-2535 | |
Dr. Laquita Ann Shepherd, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 N Belt Line Rd Ste 105, Mesquite, TX 75149 Phone: 972-686-1234 Fax: 972-686-9000 | |
Dr. Valerie A Peterson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1575 I 30, Mesquite, TX 75150 Phone: 469-800-2800 Fax: 469-800-2801 | |
Richard Allan Berlando, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2540 North Galloway, Suite 203, Mesquite, TX 75150 Phone: 972-682-0700 Fax: 972-682-0779 | |
Dr. Christopher P Kampas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1575 I 30, Mesquite, TX 75150 Phone: 469-800-2800 Fax: 469-800-2801 | |
Donald Dillahunty, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1280 N Town East Blvd, Mesquite, TX 75150 Phone: 972-686-1880 Fax: 972-686-5845 | |
Dr. Urooj Shibli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 Us Highway 80 E, Mesquite, TX 75149 Phone: 469-827-7300 Fax: 469-202-0120 |